Bone loss in patients with breast or prostate cancer.

Current Osteoporosis Reports
Mimi I HuCamilo Jimenez

Abstract

Cancers of the breast and prostate are very common in the general population, with breast cancer accounting worldwide for 23% of cancer cases in women and prostate cancer accounting for 12% of cases in men. During the past decade, the survival rates of patients with estrogen-dependent breast cancer and testosterone-dependent prostate cancer have improved. This improvement has been possible thanks to the introduction of hormone treatments that suppress the synthesis or antagonize the actions of gonadal steroids. However, estrogen and testosterone deficiencies are associated with excessive bone resorption that translates into damage of the bone microarchitecture, loss of bone mineral density, and predisposition to osteoporosis and fractures. Herein, we review the mechanisms of bone loss in breast and prostate cancer survivors, their clinical implications, and different available therapeutic modalities that may help to correct the damage of bone and prevent the development of fractures.

References

Dec 3, 1992·The New England Journal of Medicine·M C ChapuyP J Meunier
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·S M PierceJ R Harris
Aug 1, 1995·Calcified Tissue International·S ErikssonK Carlström
May 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J BinesM A Cobleigh
Mar 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P D DelmasA Bremond
May 20, 1998·Journal of the National Cancer Institute·T J PowlesJ Kanis
Nov 26, 1998·The New England Journal of Medicine·C K Osborne
Mar 31, 1999·British Journal of Cancer·J A KanisT Spector
May 5, 1999·JAMA : the Journal of the American Medical Association·M S LeBoffJ Glowacki
Jul 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C L ShapiroM Leboff
Sep 29, 2001·The New England Journal of Medicine·M R SmithJ S Finkelstein
Aug 6, 2002·The Journal of Clinical Endocrinology and Metabolism·Daniella MittanJan M Bruder
Apr 8, 2003·The Journal of Clinical Endocrinology and Metabolism·Maria BenitoPeter J Snyder
Apr 11, 2003·The Journal of Urology·L Joseph MeltonHorst Zincke
Sep 10, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce E HillnerUNKNOWN American Society of Clinical Oncology
Aug 5, 2004·The Journal of Clinical Endocrinology and Metabolism·Matthew R SmithJoel S Finkelstein
Sep 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Paul E GossKenneth P H Pritzker
Sep 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A SverrisdóttirL E Rutqvist
Nov 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric P WinerMark R Somerfield
Mar 4, 2005·Breast Cancer Research : BCR·Kathy Pritchard, Tim Whelan
Mar 17, 2005·The Journal of Clinical Endocrinology and Metabolism·Ghada El-Hajj FuleihanAli Shamseddine
May 20, 2005·Endocrine Reviews·Katrien JanssensWim Van Hul
Feb 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leena VehmanenTiina Saarto
Jun 7, 2006·JAMA : the Journal of the American Medical Association·Victor G VogelUNKNOWN National Surgical Adjuvant Breast and Bowel Project (NSABP)
Jul 11, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edith A PerezPaul E Goss
Jul 28, 2006·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Richard EastellUNKNOWN ATAC Trialists' group
Aug 5, 2006·The Lancet Oncology·UNKNOWN Arimidex, Tamoxifen, Alone or in Combination Trialists' GroupJ M Nabholtz
Oct 19, 2006·The Journal of Clinical Endocrinology and Metabolism·Susan L GreenspanVictor G Vogel
Nov 18, 2006·The Oncologist·Theresa A Guise
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael F X GnantUNKNOWN Austrian Breast and Colorectal Cancer Study Group
Jan 4, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alan S CoatesAron Goldhirsch
Dec 13, 2007·International Journal of Cancer. Journal International Du Cancer·Shehnaz K HussainKari Hemminki

❮ Previous
Next ❯

Citations

Oct 23, 2013·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·R RizzoliUNKNOWN International Osteoporosis Foundation Committee of Scientific Advisors Working Group on Cancer-Induced Bone Disease
Feb 26, 2009·Journal of Cancer Survivorship : Research and Practice·Ellen Karine GrovAlv A Dahl
Nov 3, 2015·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Soo Hyun KimEunju Choi
Oct 28, 2015·Nature Reviews. Endocrinology·Issam MakhoulLarry J Suva
Mar 23, 2010·The Journal of Steroid Biochemistry and Molecular Biology·Hubert W Vesper, Julianne Cook Botelho
May 5, 2009·Journal of Cancer Survivorship : Research and Practice·Charles J StavaRena Vassilopoulou-Sellin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.